Welcome to Leukemia

Leading journal covering all aspects of the research and treatment of leukemia and allied diseases.

Announcements

  • covid image

    During this extraordinary time Leukemia is committed to providing research which will help our readers care for people with haematological disorders at risk of SARS-CoV2-infection and COVID-19. This collection showcases the articles published thus far.

  • A sincere thank you to all of the reviewers listed here, who took the time to review for Leukemia in 2020. The journal could not exist without the knowledge and critical evaluation provided by our reviewers - content is often vastly improved by the suggestions and recommendations they provide.

  • Join Nature Cancer's Chief Editor, Alexia-Ileana Zaromytidou, alongside Prof Adrian Harris, Drs Jan-Paul Medema, Haidong Dong, and Yi-Long Wu, for the first in a new series of Springer Nature webinars that will bring together international experts to discuss ongoing developments in cancer research.

    Thursday 24 June 2021, 8-9.30 am (EDT), 2-3.30 pm (CET), 8-9.30 pm (CST)

Leukemia is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.

Advertisement

Caring for those with haematological disorders during the Covid-19 pandemic

Caring for those with haematological disorders during the Covid-19 pandemic

During this extraordinary time Leukemia is committed to providing research which will help our readers care for people with haematological disorders at risk of SARS-CoV2-infection and COVID-19. We encourage you to submit relevant research or correspondence, which whilst keeping our high standards of quality and accuracy, will be expedited through peer review and rapidly published online. Below is a selection of article already published – more to follow soon. All research featured in this collection will be free to access until the end of the pandemic.
Collection